Opendata, web and dolomites

BILISTICK

BILISTICK: A low cost point-of-care for early diagnosis of hyperbilirubinemia in newborns

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BILISTICK project word cloud

Explore the words cloud of the BILISTICK project. It provides you a very rough idea of what is the project "BILISTICK" about.

marketing    device    worst    vitro    thousands    neurological    applicable    team    business    academic    examination    feasibility    technologies    emphasis    permanent    consequent    invasive    universal    blood    solutions    economical    mainly    kidney    hyperbilirubinemia    dis    aap    giving    guidelines    bilistick    plan    entrepreneurial    healthcare    prevent    diagnostic    purpose    biomarkers    national    expensive    discharge    follow    damage    huge    care    accurate    converging    oriented    pricing    largely    individualized    disease    portable    competitors    of    post    international    professional    company    acceptance    put    functions    core    diagnosis    point    bilirubin    spin    market    recommend    preventable    medical    newborns    severe    minimally    promptly    innovative    consequence    measuring    heart    union    kernicterus    university    trieste    off    rapid    liver    nature    acquired    screening    bilimetrix    solution    viewpoint   

Project "BILISTICK" data sheet

The following table provides information about the project.

Coordinator
BILIMETRIX SRL 

Organization address
address: AREA SCIENCE PARK ED Q
city: TRIESTE
postcode: 34149
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.bilimetrix.net
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-02-01   to  2016-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BILIMETRIX SRL IT (TRIESTE) coordinator 50˙000.00

Map

 Project objective

The objective of the overall project is to lead to the international market “Bilistick”, an innovative low-cost Point-of-Care for early diagnosis of hyperbilirubinemia. The system aims to prevent, through early diagnosis, the permanent neurological damage that severe hyperbilirubinemia can cause in newborns.Every year in European Union there are about 3 thousands cases of kernicterus (worst consequence of hyperbilirubinemia) determining consequent huge costs for National Healthcare Systems. Kernicterus is a largely preventable disease if severe hyperbilirubinemia is identified early and promptly treated. For this reason AAP Guidelines (adopted by EU) recommend universal bilirubin screening and individualized post-discharge follow-up care based on results of such screening. However existing solutions are expensive, not portable or not enough accurate. Bilistick is the only in vitro rapid diagnostic device for measuring the level of bilirubin in the blood of newborns. It is low cost, minimally invasive, portable, giving rapid response, accurate and applicable in all newborns. It is the result of experience acquired during years of academic and professional research carried out by the entrepreneurial team of Bilimetrix s.r.l.. Bilimetrix s.r.l. is a spin-off of the University of Trieste, established as a research and development company. Its core business is development of medical devices based on advanced technologies oriented on liver, kidney and heart dis-functions. All solution are mainly based on new biomarkers. The purpose of the feasibility study is a comprehensive examination of all aspects of feasibility of the project, from the technical to the economical viewpoint, converging in a detailed business plan for application in Phase 2. Emphasis will be put on market analysis (nature of the market, type of users, competitors in the market, pricing systems, methods of distribution and marketing) and then on examination of the market acceptance towards Bilistick

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BILISTICK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BILISTICK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More